Softhale

Softhale is a privately-owned respiratory company headquartered in Belgium, focused on developing pharmaceutical products with superior clinical performance based on our differentiated technology delivered through next-generation pulmonary Soft Mist Inhaler (SMI) devices. The company’s proprietary, propellant-free, purely mechanical device delivers medication to the lungs more effectively than other types of inhalers and has the potential to transform treatment paradigms in large markets, including asthma and COPD. Softhale's products for pharmaceutical development and approval processes are innovative and cost-optimized.